$3.62T
Total marketcap
$153.57B
Total volume
BTC 60.63%     ETH 8.86%
Dominance

ACOGF Stock

5.73 {{ price }} 0.000000% {{change_pct}}%
Market Cap
0
LOW - HIGH [24H]
0.0000 - 0.0000
VOLUME [24H]
0
{{ volume }}
P/E Ratio
0
Earnings per share
0

Price Chart

ACOGF Financial and Trading Overview

stock price 5.73
Previous Close 0.18
Open 0.18
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.18 - 0.18
52 Week Range 0.15 - 0.68
Volume 1K
Avg. Volume 2.07K
Market Cap 17.28M
Beta (5Y Monthly) 2.874433
PE Ratio (TTM) N/A
EPS (TTM) 0
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 2.25

ACOGF Valuation Measures

Enterprise Value 12.93M
Trailing P/E N/A
Forward P/E 1.1250001
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 12.000001
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.044

Trading Information

Stock Price History

Beta (5Y Monthly) 2.874433
52-Week Change -59.54%
S&P500 52-Week Change 20.43%
52 Week High 0.68
52 Week Low 0.15
50-Day Moving Average 0.18
200-Day Moving Average 0.25

ACOGF Share Statistics

Avg. Volume (3 month) 2.07K
Avg. Daily Volume (10-Days) 1.7K
Shares Outstanding 86.9M
Float 62.63M
Short Ratio N/A
% Held by Insiders 20.95%
% Held by Institutions 11.43%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -101.82%
Return on Equity (ttm) -270.77%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -12384357
Net Income Avi to Common (ttm) -11062846
Diluted EPS (ttm) -0.16
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 3.88M
Total Cash Per Share (mrq) 0.05
Total Debt (mrq) 1.17M
Total Debt/Equity (mrq) 88.51
Current Ratio (mrq) 2.035
Book Value Per Share (mrq) 0.015

Cash Flow Statement

Operating Cash Flow (ttm) -9254083
Levered Free Cash Flow (ttm) -4274150

Profile of

Country United States
State BC
City Vancouver
Address 301–1228 Hamilton Street
ZIP V6B 6L2
Phone 604-564-9244
Website https://www.alphacognition.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Alpha Cognition Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). It develops ALPHA-1062, an acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer's type and mild traumatic brain injury; ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.

Q&A For Stock

What is a current ACOGF stock price?

ACOGF stock price today per share is 5.73 .

How to purchase stock?

You can buy ACOGF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ?

The stock symbol or ticker of is ACOGF.

Which industry does the company belong to?

The industry is Biotechnology.

How many shares does have in circulation?

The max supply of shares is 0.

What is Price to Earnings Ratio (PE Ratio)?

PE Ratio is 0.00000000 now.

What was earnings per share over the trailing 12 months (TTM)?

EPS is 0 over the trailing 12 months.

Which sector does the company belong to?

The sector is Healthcare.

Stocks Related By Sector

Stocks Related By Industry

Stocks Related By Marketcap